A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Research payments
$7,520,174
Through program year 2022, $7,520,174 in research payments was reported against A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression, across 1,801 payments, paid by LivaNova USA, Inc..
- Paid by
- LivaNova USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $3,372,759 | 720 |
| 2021 | Research | $3,328,160 | 886 |
| 2020 | Research | $809,755 | 193 |
| 2019 | Research | $9,500 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Matthew Berger Moosic, PA Named on 63 payments
- Walter Duffy Lincoln, NE Named on 62 payments
- Mohd Malik Weldon Spring, MO Named on 58 payments
- Mary Stedman Tampa, FL Named on 55 payments
- William Hapworth New York, NY Named on 55 payments
- Michael Banov Marietta, GA Named on 54 payments
- Gustavo Alva Costa Mesa, CA Named on 53 payments
- Rebecca Allen Boston, MA Named on 51 payments
- Scott Aaronson Towson, MD Named on 49 payments
- Todd Antin Decatur, GA Named on 46 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.